New cancer clinical trial: Evaluation of Oncoxin-Viusid® in Cervical Cancer and Endometrial Adenocarcinoma.

Published on: May 30, 2018 at 12:00PM
Conditions:   Cervical Carcinoma Stage II;   Cervical Carcinoma Stage III;   Cervical Carcinoma Stage IV;   Endometrial Adenocarcinoma Stage II;   Endometrial Adenocarcinoma Stage III;   Endometrial Adenocarcinoma Stage IV
Interventions:   Dietary Supplement: Oncoxin-Viusid®;   Dietary Supplement: Placebo
Sponsor:   Catalysis SL
Recruiting
https://ift.tt/2J4bkqn